(Q67134137)

English

Safety and Immunogenicity of Norovirus Bivalent Virus-Like Particle Vaccine in Healthy Adults

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Phase II, Randomized, Placebo-controlled, Double-blind, Safety and Immunogenicity Trial of Intramuscular Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in Healthy Adults (English)

0 references

country

United States of America

0 references

start time

15 May 2014

0 references

end time

6 January 2016

0 references

number of participants

454

0 references

research intervention

monophosphoryl lipid a

0 references

clinical trial phase

phase II clinical trial

0 references

minimum age

18 year

0 references

maximum age

49 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT02142504

0 references

(Q67134137)

Safety and Immunogenicity of Norovirus Bivalent Virus-Like Particle Vaccine in Healthy Adults

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)